APBJC 2024

Call for Submission

The Asia & Pacific Bioinformatics Joint Conference (APBJC) is a collaborative platform aimed at expediting the advancement of bioinformatics in the Asia & Pacific region. This joint initiative is primarily organized by the Japanese Society for Bioinformatics (JSBi), Asia - Pacific Bioinformatics Network (APBioNET), International Society for Computational Biology (ISCB), the International Conference on Genome Informatics (GIW), and the Asia-Pacific Bioinformatics Conference (APBC). APBJC also benefits from the active involvement and support of numerous regional bioinformatics societies, reflecting a collective commitment to fostering progress and innovation in the field.

APBJC 2024 welcomes abstract submissions featuring research at the forefront of bioinformatics and computational biology. We encourage the submission of original work, whether it is in progress or has been previously published within the last 18 months, for consideration for oral and/or poster presentation.

All presentations are categorized based on scientific topics, ensuring a cohesive organization of talks and posters. Please ensure that your abstract communicates a scientific result and refrains from serving as an advertisement for any commercial software package or products.

APBJC 2024 embraces a broad interpretation of bioinformatics/computational biology. Topics of particular interest encompass, but are not limited to, the following:

SINGLE-CELL ANALYSIS:
AI AND THEIR APPLICATIONS:
PROTEIN/RNA STRUCTURE ANALYSIS, PREDICTION AND DESIGN:
PERSONALIZED MEDICINE AND COMPUTATIONAL GENETICS:
METAGENOMICS AND MICROBIOME ANALYSIS:
NETWORK BIOLOGY AND SYSTEMS BIOLOGY:
DRUG DISCOVERY AND REPURPOSING:
ETHICAL, LEGAL AND SOCIAL ISSUES(ELSI):
BIOINFORMATICS EDUCATION:
OMICS-Based INFORMATICS:
DATABASES, ONTOLOGIES AND BIOCURATION:
EVOLUTIONARY, COMPARATIVE GENOMICS AND PHYLOGENETICS:
SYNTHETIC BIOLOGY AND ENGINEERING:
GENERAL COMPUTATIONAL BIOLOGY:
OTHERS:

Guidelines for Multiple talks

To ensure diverse content and maximize participation, the same oral presentation is not permitted to be delivered more than once at APBJC 2024. However, research may be presented in both oral and poster formats. While having the same individual present two (or more) distinct talks is allowed, it is not encouraged. Furthermore, while a presenting author is welcome to present more than one poster, these should not be posters which are scheduled in the same poster session. We strongly encourage labs to engage multiple lab members to foster a collaborative and comprehensive representation of their research efforts.

Abstracts: Deadlines

Any recent research, published or unpublished, is eligible for submission and should be received by July 7. Acceptance notifications will be sent no later than July 28. The conference will accept late poster abstracts beginning July 30 and ending August 7.

Abstracts: Submission Guidelines

The presenter should be identified during the submission process. Presenters of accepted abstracts are required to make the presentation themselves, and must register and pay to attend the conference.

Submitters may choose to have their submission reviewed for: (i) talk only, (ii) talk and poster or (iii) poster only. If you select talk and poster, and are unsuccessful for a talk, your abstract will automatically be considered for a poster presentation. Submissions must be received by July 7.

Participants who opt for (i) talk only or (ii) talk and poster are required to submit:
Both a 200-word abstract to be posted on the conference website AND a long abstract of up to two (2) pages in PDF format.
Participants who opt for (iii) poster only are required to submit:
A 200-word abstract to be posted on the conference website.
  • All abstracts must be submitted using the conference submission site by the abstract deadline: July 7.
  • The 200-word abstract should be a brief and concise summary of the background/motivation for the study, method and result(s), as well as conclusion/statement of significance. The abstract is submitted through the EasyChair submission system.
  • Accepted abstracts (maximum 200 words) will be posted on the conference web site.
  • For authors requesting a talk you should upload a long abstract of up to two (2) pages in PDF format during the submission process, to provide additional details including figures and graphics that support the main points of the abstract. *Do not submit more than two pages*
  • Your abstract must not contain your title/position or any personal information (e.g. affiliation). These details will be collected through the EasyChair submission system.
  • Selected Abstract talks will be presented in tracks that run in parallel at the conference.

Abstracts: Review Criteria

All submissions will be evaluated by a program committee. Submitters may choose to have their submission reviewed for talk only, talk and poster, or poster only. If you select talk and poster and are unsuccessful for a talk, your abstract will automatically be considered for a poster.

Posters advertising commercial software and products will be rejected and/or removed from the conference without notice.

Presentation Commitment

We strongly encourage in-person presentations at the conference venue for all abstracts accepted for oral presentation at APBJC 2024. However, we recognize that certain circumstances may prevent presenters from attending in person. For presenters facing challenges related to maternity/paternity leave, family care responsibilities, personal/medical disability, illness, financial constraints, or potential visa issues, APBJC 2024 offers remote presentation options. If your abstract is accepted for oral presentation and you are unable to present in person, we require you to submit a waiver request at the time of acceptance. Please send your request to presentationwaiver@iscb.org no later than September 1.

Note that all oral presentations will be recorded to be made available via a content capture system.

We appreciate your cooperation in ensuring a diverse and inclusive participation at APBJC 2024.